Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus + Tacrolimus vs Cyclosporine + Methotrexate in Allo-HSCT
NCT00993343Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Sep 2007
- Primary completion
- Feb 2015
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus, tacrolimus in graft-versus-host disease (GVHD), sponsored by Karolinska Institutet. Started Sep 2007; status: completed.
02
Drugs
sirolimustacrolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00993343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993343.